NSE filing, NSE: AJOONI. Summary written from the filing by ALFA Finder's alert engine.
Ajooni Biotech Ltd: key numbers
- Share price
- ₹2.90
- Market cap
- ₹49.95 Cr
- Revenue (annual)
- ₹182.4 Cr
- Net profit (annual)
- ₹4.32 Cr
- P/E (TTM)
- 12.6×Sector 27.1×
- Promoter holding
- 30.53%+3.64% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ajooni Biotech Ltd
All →Ajooni Biotech Other Announcement
Ajooni Biotech informed NSE that its website is updated and functional per Reg 46 of SEBI LODR. This is a routine compliance intimation with no business or financial substance.
Ajooni Biotech Q1 FY27 Results: Net Profit ₹0.4 Cr, Down 50.0% YoY
Ajooni Biotech Ltd reported revenue from operations of ₹63.5 Cr (+102.9% YoY) and net profit of ₹0.4 Cr (-50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.4 Cr · -50.0% YoY
Ajooni Biotech Capital Structure Change
Ajooni Biotech has allotted 90 lakh equity shares to Healthy Biosciences Limited. The total issue value is ₹3.87 Crore.
- Value
- ₹3.87 Cr
Ajooni Biotech Board Meeting Date
Ajooni Biotech Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve unaudited standalone financial results for the June 2026 quarter.
Ajooni Biotech Capital Structure Change
The company's shareholders approved an increase in its authorized share capital to ₹70 Crore at the 16th Annual General Meeting.
Ajooni Biotech Capital Structure Change
Ajooni Biotech received shareholder approval for the preferential issuance of 90,00,000 equity shares at Rs. 4.30 each, valued at approximately ₹3.87 Crore.
- Value
- ₹3.87 Cr
Other management change announcements
All →Kaira Can Company Management Change
Kaira Can Company appointed Mr. Bharat A. Kapadia as Additional Director (Non-Executive, Non-Independent) effective 30 October 2026. The appointment brings his business-development experience to the board.
Intellect Design Arena Management Change
Intellect Design Arena appointed Suresh Eshwara Prabhala as Non-Executive Independent Director for a 60-month term. The board meeting approving this was held on 30 October 2026.
Western Overseas Study Abroad Management Change
Western Overseas Study Abroad Ltd disclosed that Non-Executive Director Mr. Deepak Kumar resigned effective 30 October 2026. The board will note the resignation, citing other work commitments.
Divgi Torqtransfer Systems Management Change
Divgi TorqTransfer Systems appointed Mr. Sarang Deshpande as Company Secretary and Compliance Officer. Ms. Ishita Kokare resigned that role effective October 30, 2026.
Religare Enterprises Management Change
Religare Enterprises appointed Ms. Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer w.e.f. October 31, 2026. She was designated as a Key Managerial Personnel.
Amanta Healthcare Management Change
Amanta Healthcare's COO Shri Anil Rathi resigned effective October 29, 2026. The departure is disclosed under Regulation 30 of the SEBI Listing Regulations.